Kinetics of mammary epithelial cell proliferation in pituitary isografted BALB/c mice

Authors:
  • SSSteven M. Swanson
    Steven M. Swanson
  • RGRaphael C. Guzman
    Raphael C. Guzman
  • SNSatyabrata Nandi
    Satyabrata Nandi

Abstract
Recently, we have published that treatment of pituitary isografted BALB/c mice with a single injection of N-methyl-N-nitrosourea (MNU) leads to the rapid development of mammary tumors in over 90% of the animals (Guzman et al., Cancer Res., 52, 5732–5737). In the present study, we characterized the changes in proliferative activity and lobulo—alveolar differentiation of MECs at different time intervals after isografting animals with pituitary glands. Virgin BALB/c mice 1, 3, 5 or 8 weeks after pituitary isografting were either pulse-labeled for 2 h or continuously infused with bromodeoxyuridine (BrdU) and the percentage of BrdU-labeled MECs was assessed. The S-phase duration (Ts) of MECs was evaluated by double labeling with [3H]thymidine and BrdU. The population potential doubling time (Tp) was calculated from the values of BrdU-LI and Ts. Three stages of proliferation and differentiation of MECs in pituitary isografted virgin BALB/c mice were observed: (i) A sharp increase in the percentage of proliferating MECs of the terminal ducts and ductal branchings in the first 1–2 weeks, (ii) Development of lobulo—alveolar structures from the terminal ductal and alveolar buds, between weeks 3 and 5 with the highest BrdU-LI in week 3 and (iii) Multiplication of the alveolar structures and decrease in the BrdU-LI between weeks 5 and 8. The BrdU-LIs of alveolar cells 5 weeks after isografting the animals were significantly higher than those of the ductal cells. The continuous administration of BrdU for 3, 5 or 7 days by using osmotic pumps revealed zones in the ducts where almost all MECs were labeled as well as zones lacking proliferate activity. When the BrdU administration was extended for 10–14 days, almost all (>95%) ductal and lobular epithelial cells were labeled. A small percentage (s and Tp values were shorter in pituitary isografted animals than in controls, but no significant difference was found for either values between the ductal and alveolar cells in either isografted or control mice. Changes in proliferation kinetics of mouse MECs in pituitary isografted animals correlated with the circulating concentrations of prolactin, progesterone and 17β-estradiol, but not with corticosterone, growth hormone or thyroxin. We propose that these time dependent differences in the structural composition and proliferative activity of MECs in pituitary isografted animals can be used as a model system for evaluation of the role of cell proliferation and differentiation in mammary carcinogenesis. In a parallel study, we used this model system to induce mammary tumors by a single injection of MNU in mice isografted with pituitaries for 1, 3, 5 or 8 weeks. We observed that MNU induced mammary carcinogenesis in pituitary isografted animals required elevated proliferative activity of MECs at the time of carcinogen administration (Swanson et al., submitted).